Lorelei D. Davis
Chief Tech/Sci/R&D Officer at Frantz BioMarkers LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Truitt | M | - |
Ash Access Technology, Inc.
 Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 years |
| Stephen R. Ash | M | 78 |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 years |
| Nels P. Bergmark | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 32 years |
| Hal B. Heaton | M | 73 |
Brigham Young University
| 41 years |
| Norman R. Weldon | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Gary Lehman | M | 71 |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Daniel J. Olson | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 19 years |
| Joseph H. Broecker | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Adel B. Korkor | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Domenick P. Treschitta | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| R. Thompson | M | 73 |
Brigham Young University
| 12 years |
| Michael K. Skinner | M | - |
LPL Technologies, Inc.
 LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | 13 years |
| Gordon B. Mills | M | - |
LPL Technologies, Inc.
LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | 13 years |
| Jeff Brimhall | M | - |
Brigham Young University
| 6 years |
| Ron F. Gibbs | M | - |
Brigham Young University
| 7 years |
| Randall E. Johnson | M | 68 |
Brigham Young University
| 6 years |
| Steven T. Adams | M | - |
Brigham Young University
| 7 years |
| Steven B. Andersen | M | - |
Brigham Young University
| 7 years |
| Corey Smith | M | - |
Brigham Young University
| 6 years |
| Hal Anderson | M | - |
Brigham Young University
| 4 years |
| Lon Edgar Henderson | M | - |
Brigham Young University
| 39 years |
| Xin Ming Mu | M | 67 |
The University of North Carolina at Asheville
| 3 years |
| Tim Layton | M | - |
Brigham Young University
| 5 years |
| D. Bullock | M | 68 |
Brigham Young University
| 10 years |
| Mike K. Lee | M | 65 |
Brigham Young University
| 6 years |
| Bruce D. Stocks | M | - |
Brigham Young University
| 7 years |
| Philip M. Rees | M | 62 |
The University of North Carolina at Asheville
| 8 years |
| Kevin W. Markham | M | - |
The University of North Carolina at Asheville
| 6 years |
| Calvin W. Collins | M | 65 |
Brigham Young University
| 7 years |
| Douglas Peterson | M | 71 |
Brigham Young University
| 8 years |
| Artell Smith | M | - |
Brigham Young University
| 5 years |
| Craig H. Christensen | M | - |
Brigham Young University
| 7 years |
| Rhonda Powell | F | - |
Brigham Young University
| 5 years |
| Jay G. Heiner | M | - |
Brigham Young University
| 5 years |
| Richard Moss | M | 66 |
Brigham Young University
| 7 years |
| David Jenkins | M | 69 |
Brigham Young University
| 6 years |
| Sidney Calvin Hooper | M | 65 |
Brigham Young University
| 5 years |
| Sterling Eugene Russell | M | - |
Brigham Young University
| 5 years |
| Rodney Wilkinson | M | 69 |
Brigham Young University
| 6 years |
| Jon R. Hickman | M | - |
Brigham Young University
| 8 years |
| Stephen M. Bunker | M | 65 |
Brigham Young University
| 5 years |
| James Engebretsen | M | 68 |
Brigham Young University
| 7 years |
| John P. Livingstone | M | 73 |
Brigham Young University
| 3 years |
| Gregory Peterson | M | 63 |
Brigham Young University
| 4 years |
| Richard W. Hasler | M | - |
Brigham Young University
| 4 years |
| Michael Kenneth Boren | M | - |
Brigham Young University
| 4 years |
| Jerry Andrew Rose | M | 65 |
Brigham Young University
| 4 years |
| Jace Jergensen | M | 60 |
Brigham Young University
| 4 years |
| Trent Searle | M | - |
Brigham Young University
| 4 years |
| Greg P. Lovell | M | 64 |
Brigham Young University
| 4 years |
| Kent Thomas | M | - |
Brigham Young University
| 4 years |
| Richard C. Wirthlin | M | - |
Brigham Young University
| 4 years |
| James M. Dester | M | - |
Brigham Young University
| 8 years |
| Dal Zemp | M | - |
Brigham Young University
| 8 years |
| Gary H. Stewart | M | - |
Brigham Young University
| 4 years |
| Stephen Quesenberry | M | 61 |
Brigham Young University
| 4 years |
| Benjamin J. Harper | M | - |
Brigham Young University
| 4 years |
| Randy G. Morris | M | 67 |
Brigham Young University
| 4 years |
| Christopher Aaron Wilson | M | - |
Brigham Young University
| 4 years |
| David Wayne Lysenko | M | - |
Brigham Young University
| 7 years |
| Donald Clouse | M | - |
Brigham Young University
| 6 years |
| Scott Martin Peterson | M | - |
Brigham Young University
| 4 years |
| Bryan Hunsaker | M | - |
Brigham Young University
| 4 years |
| Rory Reid | M | - |
Brigham Young University
| 4 years |
| Allen Miner | M | 63 |
Brigham Young University
| 4 years |
| Henry Eyring | M | 60 |
Brigham Young University
| 4 years |
| John R. Lund | M | - |
Brigham Young University
| 4 years |
| Kenneth Woolley | M | 77 |
Brigham Young University
| 19 years |
| David Allen Young | M | - |
Brigham Young University
| 3 years |
| Harlan M. Hatfield | M | 63 |
Brigham Young University
| 4 years |
| Don P. Duffy | M | - |
Brigham Young University
| 4 years |
| Stephen R. Covey | M | 92 |
Brigham Young University
| 26 years |
| Pete Bodine | M | 62 |
Brigham Young University
| 4 years |
| Kevin Lund | M | - |
Brigham Young University
| 4 years |
| Larry Willes | M | - |
Brigham Young University
| 4 years |
| Terry D. Peterson | M | 59 |
Brigham Young University
| 4 years |
| Alan L. Austin | M | - |
Brigham Young University
| 4 years |
| Nelson Antonio Gonzalez | M | - |
Brigham Young University
| 4 years |
| Robert J. Cardon | M | 60 |
Brigham Young University
| 4 years |
| Tim Bridgewater | M | 62 |
Brigham Young University
| 4 years |
| Brian Murphy | M | - |
Brigham Young University
| 6 years |
| T. Chris Norman | M | - |
Brigham Young University
| 4 years |
| Robert L. Wolfert | M | 70 |
LPL Technologies, Inc.
LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | 1 years |
| David Bitter | M | - |
Brigham Young University
| 4 years |
| John Romney | M | - |
Brigham Young University
| 4 years |
| John M. Fife | M | 62 |
Brigham Young University
| 7 years |
| Roger P. Flower | M | - |
Brigham Young University
| 4 years |
| Peter Edwards | M | 62 |
Brigham Young University
| 4 years |
| Richard Rife | M | - |
Brigham Young University
| 3 years |
| David G. Dame | M | - |
Brigham Young University
| 4 years |
| Matthew J. Salmon | M | 66 |
Brigham Young University
| 4 years |
| David Rudd | M | - |
Brigham Young University
| 4 years |
| Richard M. Hartvigsen | M | - |
Brigham Young University
| 4 years |
| Michael Peterson | M | 63 |
Brigham Young University
| 4 years |
| Geoffrey D. Lewis | M | 66 |
Brigham Young University
| 4 years |
| C. Clay | M | - |
Brigham Young University
| 5 years |
| Thomas R. Ingersoll | M | - |
Brigham Young University
| 4 years |
| Scott Petty | M | 61 |
Brigham Young University
| 6 years |
| Ron P. Mika | M | - |
Brigham Young University
| 6 years |
| Ronald Felt | M | 66 |
Brigham Young University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lorelei D. Davis
- Personal Network
